 | • レポートコード：GIR-2104Z09952 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、NGS（次世代シーケンシング）RNAシーケンスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。NGS（次世代シーケンシング）RNAシーケンスの種類別市場規模（ハイスループットシーケンシング、第3世代シーケンシングテクノロジー）、用途別市場規模（病院・診療所、バイオ医薬品産業、政府、学術・研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・NGS（次世代シーケンシング）RNAシーケンスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Illumina、Thermo Fisher Scientific、Pacific Biosciences Of California、Qaigen、F. Hoffmann-La Roche、Agilent Technologies、Oxford Nanopore Technologies、Perkinelmer、Eurofins Scientific、Gatc Biotech、Macrogen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ハイスループットシーケンシング、第3世代シーケンシングテクノロジー ・用途別分析2016年-2026年：病院・診療所、バイオ医薬品産業、政府、学術・研究機関、その他 ・NGS（次世代シーケンシング）RNAシーケンスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・NGS（次世代シーケンシング）RNAシーケンスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・NGS（次世代シーケンシング）RNAシーケンスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・NGS（次世代シーケンシング）RNAシーケンスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・NGS（次世代シーケンシング）RNAシーケンスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The NGS-based RNA-seq market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global NGS-based RNA-seq size is estimated to be USD 2189.5 million in 2025 from USD 1450 million in 2019, with a change XX% between 2019 and 2020. The global NGS-based RNA-seq market size is expected to grow at a CAGR of 10.9% for the next five years.
Market segmentation
NGS-based RNA-seq market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
High-Throughput Sequencing
Third-Generation Sequencing Technology
Market segment by Application, can be divided into
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of NGS-based RNA-seq
1.2 Classification of NGS-based RNA-seq by Type
1.2.1 Overview: Global NGS-based RNA-seq Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global NGS-based RNA-seq Revenue Market Share by Type in 2020
1.2.3 High-Throughput Sequencing
1.2.4 Third-Generation Sequencing Technology
1.3 Global NGS-based RNA-seq Market by Application
1.3.1 Overview: Global NGS-based RNA-seq Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Government Agencies
1.3.5 Academic and Research Organizations
1.3.6 Other
1.4 Global NGS-based RNA-seq Market Size & Forecast
1.5 Global NGS-based RNA-seq Market Size and Forecast by Region
1.5.1 Global NGS-based RNA-seq Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global NGS-based RNA-seq Market Size by Region, (2016-2021)
1.5.3 North America NGS-based RNA-seq Market Size and Prospect (2016-2026)
1.5.4 Europe NGS-based RNA-seq Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific NGS-based RNA-seq Market Size and Prospect (2016-2026)
1.5.6 South America NGS-based RNA-seq Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa NGS-based RNA-seq Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 NGS-based RNA-seq Market Drivers
1.6.2 NGS-based RNA-seq Market Restraints
1.6.3 NGS-based RNA-seq Trends Analysis
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina NGS-based RNA-seq Product and Solutions
2.1.4 Illumina NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific NGS-based RNA-seq Product and Solutions
2.2.4 Thermo Fisher Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Pacific Biosciences Of California
2.3.1 Pacific Biosciences Of California Details
2.3.2 Pacific Biosciences Of California Major Business
2.3.3 Pacific Biosciences Of California NGS-based RNA-seq Product and Solutions
2.3.4 Pacific Biosciences Of California NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pacific Biosciences Of California Recent Developments and Future Plans
2.4 Qaigen
2.4.1 Qaigen Details
2.4.2 Qaigen Major Business
2.4.3 Qaigen NGS-based RNA-seq Product and Solutions
2.4.4 Qaigen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Qaigen Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business
2.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Product and Solutions
2.5.4 F. Hoffmann-La Roche NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business
2.6.3 Agilent Technologies NGS-based RNA-seq Product and Solutions
2.6.4 Agilent Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Agilent Technologies Recent Developments and Future Plans
2.7 Oxford Nanopore Technologies
2.7.1 Oxford Nanopore Technologies Details
2.7.2 Oxford Nanopore Technologies Major Business
2.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Product and Solutions
2.7.4 Oxford Nanopore Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.8 Perkinelmer
2.8.1 Perkinelmer Details
2.8.2 Perkinelmer Major Business
2.8.3 Perkinelmer NGS-based RNA-seq Product and Solutions
2.8.4 Perkinelmer NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Perkinelmer Recent Developments and Future Plans
2.9 Eurofins Scientific
2.9.1 Eurofins Scientific Details
2.9.2 Eurofins Scientific Major Business
2.9.3 Eurofins Scientific NGS-based RNA-seq Product and Solutions
2.9.4 Eurofins Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Eurofins Scientific Recent Developments and Future Plans
2.10 Gatc Biotech
2.10.1 Gatc Biotech Details
2.10.2 Gatc Biotech Major Business
2.10.3 Gatc Biotech NGS-based RNA-seq Product and Solutions
2.10.4 Gatc Biotech NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Gatc Biotech Recent Developments and Future Plans
2.11 Macrogen
2.11.1 Macrogen Details
2.11.2 Macrogen Major Business
2.11.3 Macrogen NGS-based RNA-seq Product and Solutions
2.11.4 Macrogen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Macrogen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global NGS-based RNA-seq Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 NGS-based RNA-seq Players Market Share
3.2.2 Top 10 NGS-based RNA-seq Players Market Share
3.2.3 Market Competition Trend
3.3 NGS-based RNA-seq Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global NGS-based RNA-seq Revenue and Market Share by Type (2016-2021)
4.2 Global NGS-based RNA-seq Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global NGS-based RNA-seq Revenue Market Share by Application (2016-2021)
5.2 NGS-based RNA-seq Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America NGS-based RNA-seq Revenue by Type (2016-2026)
6.2 North America NGS-based RNA-seq Revenue by Application (2016-2026)
6.3 North America NGS-based RNA-seq Market Size by Country
6.3.1 North America NGS-based RNA-seq Revenue by Country (2016-2026)
6.3.2 United States NGS-based RNA-seq Market Size and Forecast (2016-2026)
6.3.3 Canada NGS-based RNA-seq Market Size and Forecast (2016-2026)
6.3.4 Mexico NGS-based RNA-seq Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe NGS-based RNA-seq Revenue by Type (2016-2026)
7.2 Europe NGS-based RNA-seq Revenue by Application (2016-2026)
7.3 Europe NGS-based RNA-seq Market Size by Country
7.3.1 Europe NGS-based RNA-seq Revenue by Country (2016-2026)
7.3.2 Germany NGS-based RNA-seq Market Size and Forecast (2016-2026)
7.3.3 France NGS-based RNA-seq Market Size and Forecast (2016-2026)
7.3.4 United Kingdom NGS-based RNA-seq Market Size and Forecast (2016-2026)
7.3.5 Russia NGS-based RNA-seq Market Size and Forecast (2016-2026)
7.3.6 Italy NGS-based RNA-seq Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific NGS-based RNA-seq Revenue by Type (2016-2026)
8.2 Asia-Pacific NGS-based RNA-seq Revenue by Application (2016-2026)
8.3 Asia-Pacific NGS-based RNA-seq Market Size by Region
8.3.1 Asia-Pacific NGS-based RNA-seq Revenue by Region (2016-2026)
8.3.2 China NGS-based RNA-seq Market Size and Forecast (2016-2026)
8.3.3 Japan NGS-based RNA-seq Market Size and Forecast (2016-2026)
8.3.4 South Korea NGS-based RNA-seq Market Size and Forecast (2016-2026)
8.3.5 India NGS-based RNA-seq Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia NGS-based RNA-seq Market Size and Forecast (2016-2026)
8.3.7 Australia NGS-based RNA-seq Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America NGS-based RNA-seq Revenue by Type (2016-2026)
9.2 South America NGS-based RNA-seq Revenue by Application (2016-2026)
9.3 South America NGS-based RNA-seq Market Size by Country
9.3.1 South America NGS-based RNA-seq Revenue by Country (2016-2026)
9.3.2 Brazil NGS-based RNA-seq Market Size and Forecast (2016-2026)
9.3.3 Argentina NGS-based RNA-seq Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa NGS-based RNA-seq Revenue by Type (2016-2026)
10.2 Middle East & Africa NGS-based RNA-seq Revenue by Application (2016-2026)
10.3 Middle East & Africa NGS-based RNA-seq Market Size by Country
10.3.1 Middle East & Africa NGS-based RNA-seq Revenue by Country (2016-2026)
10.3.2 Turkey NGS-based RNA-seq Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia NGS-based RNA-seq Market Size and Forecast (2016-2026)
10.3.4 UAE NGS-based RNA-seq Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global NGS-based RNA-seq Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global NGS-based RNA-seq Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market NGS-based RNA-seq Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global NGS-based RNA-seq Revenue (USD Million) by Region (2016-2021)
Table 5. Global NGS-based RNA-seq Revenue Market Share by Region (2021-2026)
Table 6. Illumina Corporate Information, Head Office, and Major Competitors
Table 7. Illumina Major Business
Table 8. Illumina NGS-based RNA-seq Product and Solutions
Table 9. Illumina NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific NGS-based RNA-seq Product and Solutions
Table 13. Thermo Fisher Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pacific Biosciences Of California Corporate Information, Head Office, and Major Competitors
Table 15. Pacific Biosciences Of California Major Business
Table 16. Pacific Biosciences Of California NGS-based RNA-seq Product and Solutions
Table 17. Pacific Biosciences Of California NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Qaigen Corporate Information, Head Office, and Major Competitors
Table 19. Qaigen Major Business
Table 20. Qaigen NGS-based RNA-seq Product and Solutions
Table 21. Qaigen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche Major Business
Table 24. F. Hoffmann-La Roche NGS-based RNA-seq Product and Solutions
Table 25. F. Hoffmann-La Roche NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 27. Agilent Technologies Major Business
Table 28. Agilent Technologies NGS-based RNA-seq Product and Solutions
Table 29. Agilent Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Oxford Nanopore Technologies Corporate Information, Head Office, and Major Competitors
Table 31. Oxford Nanopore Technologies Major Business
Table 32. Oxford Nanopore Technologies NGS-based RNA-seq Product and Solutions
Table 33. Oxford Nanopore Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Perkinelmer Corporate Information, Head Office, and Major Competitors
Table 35. Perkinelmer Major Business
Table 36. Perkinelmer NGS-based RNA-seq Product and Solutions
Table 37. Perkinelmer NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 39. Eurofins Scientific Major Business
Table 40. Eurofins Scientific NGS-based RNA-seq Product and Solutions
Table 41. Eurofins Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Gatc Biotech Corporate Information, Head Office, and Major Competitors
Table 43. Gatc Biotech Major Business
Table 44. Gatc Biotech NGS-based RNA-seq Product and Solutions
Table 45. Gatc Biotech NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Macrogen Corporate Information, Head Office, and Major Competitors
Table 47. Macrogen Major Business
Table 48. Macrogen NGS-based RNA-seq Product and Solutions
Table 49. Macrogen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global NGS-based RNA-seq Revenue (USD Million) by Players (2019-2021)
Table 51. Global NGS-based RNA-seq Revenue Share by Players (2019-2021)
Table 52. Breakdown of NGS-based RNA-seq by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. NGS-based RNA-seq Players Head Office, Products and Services Provided
Table 54. NGS-based RNA-seq Mergers & Acquisitions in the Past Five Years
Table 55. NGS-based RNA-seq New Entrants and Expansion Plans
Table 56. Global NGS-based RNA-seq Revenue (USD Million) by Type (2016-2021)
Table 57. Global NGS-based RNA-seq Revenue Share by Type (2016-2021)
Table 58. Global NGS-based RNA-seq Revenue Forecast by Type (2021-2026)
Table 59. Global NGS-based RNA-seq Revenue by Application (2016-2021)
Table 60. Global NGS-based RNA-seq Revenue Forecast by Application (2021-2026)
Table 61. North America NGS-based RNA-seq Revenue by Type (2016-2021) & (USD Million)
Table 62. North America NGS-based RNA-seq Revenue by Type (2021-2026) & (USD Million)
Table 63. North America NGS-based RNA-seq Revenue by Application (2016-2021) & (USD Million)
Table 64. North America NGS-based RNA-seq Revenue by Application (2021-2026) & (USD Million)
Table 65. North America NGS-based RNA-seq Revenue by Country (2016-2021) & (USD Million)
Table 66. North America NGS-based RNA-seq Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe NGS-based RNA-seq Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe NGS-based RNA-seq Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe NGS-based RNA-seq Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe NGS-based RNA-seq Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe NGS-based RNA-seq Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe NGS-based RNA-seq Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific NGS-based RNA-seq Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific NGS-based RNA-seq Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific NGS-based RNA-seq Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific NGS-based RNA-seq Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific NGS-based RNA-seq Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific NGS-based RNA-seq Revenue by Region (2021-2026) & (USD Million)
Table 79. South America NGS-based RNA-seq Revenue by Type (2016-2021) & (USD Million)
Table 80. South America NGS-based RNA-seq Revenue by Type (2021-2026) & (USD Million)
Table 81. South America NGS-based RNA-seq Revenue by Application (2016-2021) & (USD Million)
Table 82. South America NGS-based RNA-seq Revenue by Application (2021-2026) & (USD Million)
Table 83. South America NGS-based RNA-seq Revenue by Country (2016-2021) & (USD Million)
Table 84. South America NGS-based RNA-seq Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa NGS-based RNA-seq Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa NGS-based RNA-seq Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa NGS-based RNA-seq Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa NGS-based RNA-seq Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa NGS-based RNA-seq Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa NGS-based RNA-seq Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. NGS-based RNA-seq Picture
Figure 2. Global NGS-based RNA-seq Revenue Market Share by Type in 2020
Figure 3. High-Throughput Sequencing
Figure 4. Third-Generation Sequencing Technology
Figure 5. NGS-based RNA-seq Revenue Market Share by Application in 2020
Figure 6. Hospitals and Clinics Picture
Figure 7. Biopharma Companies Picture
Figure 8. Government Agencies Picture
Figure 9. Academic and Research Organizations Picture
Figure 10. Other Picture
Figure 11. Global NGS-based RNA-seq Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global NGS-based RNA-seq Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global NGS-based RNA-seq Revenue Market Share by Region (2016-2026)
Figure 14. Global NGS-based RNA-seq Revenue Market Share by Region in 2020
Figure 15. North America NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. NGS-based RNA-seq Market Drivers
Figure 20. NGS-based RNA-seq Market Restraints
Figure 21. NGS-based RNA-seq Market Trends
Figure 22. Illumina Recent Developments and Future Plans
Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 24. Pacific Biosciences Of California Recent Developments and Future Plans
Figure 25. Qaigen Recent Developments and Future Plans
Figure 26. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 27. Agilent Technologies Recent Developments and Future Plans
Figure 28. Oxford Nanopore Technologies Recent Developments and Future Plans
Figure 29. Perkinelmer Recent Developments and Future Plans
Figure 30. Eurofins Scientific Recent Developments and Future Plans
Figure 31. Gatc Biotech Recent Developments and Future Plans
Figure 32. Macrogen Recent Developments and Future Plans
Figure 34. Global NGS-based RNA-seq Revenue Share by Players in 2020
Figure 35. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players NGS-based RNA-seq Revenue Market Share in 2020
Figure 37. Global Top 10 Players NGS-based RNA-seq Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global NGS-based RNA-seq Revenue Share by Type in 2020
Figure 40. Global NGS-based RNA-seq Market Share Forecast by Type (2021-2026)
Figure 41. Global NGS-based RNA-seq Revenue Share by Application in 2020
Figure 42. Global NGS-based RNA-seq Market Share Forecast by Application (2021-2026)
Figure 43. North America NGS-based RNA-seq Sales Market Share by Type (2016-2026)
Figure 44. North America NGS-based RNA-seq Sales Market Share by Application (2016-2026)
Figure 45. North America NGS-based RNA-seq Revenue Market Share by Country (2016-2026)
Figure 46. United States NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe NGS-based RNA-seq Sales Market Share by Type (2016-2026)
Figure 50. Europe NGS-based RNA-seq Sales Market Share by Application (2016-2026)
Figure 51. Europe NGS-based RNA-seq Revenue Market Share by Country (2016-2026)
Figure 52. Germany NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific NGS-based RNA-seq Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific NGS-based RNA-seq Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific NGS-based RNA-seq Revenue Market Share by Region (2016-2026)
Figure 60. China NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America NGS-based RNA-seq Sales Market Share by Type (2016-2026)
Figure 67. South America NGS-based RNA-seq Sales Market Share by Application (2016-2026)
Figure 68. South America NGS-based RNA-seq Revenue Market Share by Country (2016-2026)
Figure 69. Brazil NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa NGS-based RNA-seq Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa NGS-based RNA-seq Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Country (2016-2026)
Figure 74. Turkey NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE NGS-based RNA-seq Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のNGSベースRNA-seq市場規模・現状・予測（2021年-2027年） Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market. The hosp…- 世界のNGSベース診断市場規模・現状・予測（2021年-2027年） Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms. North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is …
- 世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-Throughput Sequencing (HTS) Market The global High-Throughput Sequencing (HTS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-Throughput Sequencing (HTS) Market The global High-Throughput Sequencing (HTS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界のアカウントベース発券（ABT）市場規模・現状・予測（2021年-2027年） Account Based Ticketing (ABT) is a system that can open up new opportunities and business models, provide access to new markets that were previously out of reach, and provide a platform to address the reduction in the ongoing costs associated with card issuance, as well as system management and main…